Skip to main content
. 2019 Jun 6;105(3):838–848. doi: 10.3324/haematol.2019.221424

Figure 3.

Figure 3

Efficacy of anticoagulant prophylaxis for the prevention of venous thromboembolism in ambulatory cancer patients receiving chemotherapy according to the primary site of cancer.